Inmazeb

The United States Food and Drug Administration approved Regeneron Pharmaceuticals, Inc's (NASDAQ: REGN) drug Inmazeb for the treatment of Ebola in both adults and children on Wednesday. What Happened: Inmazeb is the first-ever drug approved for the treatment of the infection caused by the...